Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Sun Pharmaceutical Industries Ltd.
  6. Summary
    SUNPHARMA   INE044A01036

SUN PHARMACEUTICAL INDUSTRIES LTD.

(SUNPHARMA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nse India Stock Exchange
07/26/2021 07/27/2021 07/28/2021 07/29/2021 07/30/2021 Date
703.4(c) 688.3(c) 687.8(c) 703(c) 773.95(c) Last
4 715 053 5 327 355 3 332 667 4 397 443 35 893 710 Volume
+1.35% -2.15% -0.07% +2.21% +10.09% Change
More quotes
Estimated financial data (e)
Sales 2021 339 B 4 562 M 4 562 M
Net income 2021 37 004 M 498 M 498 M
Net cash position 2021 58 736 M 790 M 790 M
P/E ratio 2021 44,5x
Yield 2021 0,43%
Sales 2022 377 B 5 068 M 5 068 M
Net income 2022 66 953 M 901 M 901 M
Net cash position 2022 62 188 M 837 M 837 M
P/E ratio 2022 29,2x
Yield 2022 0,59%
Capitalization 1 857 B 24 976 M 24 979 M
EV / Sales 2021 5,30x
EV / Sales 2022 4,76x
Nbr of Employees 36 000
Free-Float 82,7%
More Financials
Company
Sun Pharmaceutical Industries Limited is a pharmaceuticals company. The Company's business segments include US Business, Indian Branded Generics Business, Emerging Markets, Global Consumer Healthcare Business and Active Pharmaceutical Ingredients (API). Its Rest of World segment includes Western Europe, Canada, Australia, New Zealand and other markets. The Company offers its products to therapy areas, such as... 
Sector
Pharmaceuticals
Calendar
11/11Earnings Release
More about the company
Ratings of Sun Pharmaceutical Industries Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about SUN PHARMACEUTICAL INDUSTRIES LTD.
07/30Indian Benchmarks Close the Week in Red; Sun Pharmaceutical's Stock Soars 10%
MT
07/30Sun Pharmaceutical Industries Limited Reports Earnings Results for the First ..
CI
07/30SUN PHARMACEUTICAL INDUSTRIES : Pharmaceuticals Swings to Profit in Fiscal Q1
MT
07/30EQS-ADHOC : Cosmo Half-Year Report 2021
DJ
07/29EQS-ADHOC : Cassiopea Announces Results for First Half of 2021
DJ
07/26Sun Pharma and Cassiopea SpA Announce Signing of License and Supply Agreement..
CI
07/26CASSIOPEA S P A : Enters License, Supply Deals for Acne Treatment in North Ameri..
MT
07/26EQS-ADHOC : Cosmo Pharmaceuticals Announces Cassiopea SpA's Signing of License a..
DJ
07/26EQS-ADHOC : Cassiopea SpA and Sun Pharma Announce Signing of License and Supply ..
DJ
07/13Indian shares end higher as inflation data eases policy tightening worries
RE
06/30MERCK : COVID-19 Antiviral Drug to Be Tested in India By Five Major Pharmaceutic..
MT
06/29MERCK : Five Indian Drugmakers to Begin Local Clinical Trial of Merck & Co.'s Ex..
MT
06/29Five Indian drugmakers to jointly start local trial of Merck & Co's COVID-19 ..
RE
06/15CORCEPT THERAPEUTICS INCORPORATED : Announces Settlement Deal for Patent Dispute..
MT
06/03MEDULLOBLASTOMA PIPELINE : Emerging Therapies and Key pharma players involved by..
AQ
More news
News in other languages on SUN PHARMACEUTICAL INDUSTRIES LTD.
07/30EQS-ADHOC : Halbjahresbericht 2021 von Cosmo
07/29Aktien Schweiz Vorbörse: SMI nach Fed leichter gesehen - Ergebnisse im Fokus
07/29Bei Cassiopea rücken nach Akne-Kooperation Halbjahreszahlen in Hintergrund
07/29EQS-ADHOC : Cassiopea gibt Ergebnisse des 1. Halbjahres 2021 bekannt
07/26Bourse Zurich: dans le rouge pour entamer la semaine, le SMI défend les 12'00..
More news
Analyst Recommendations on SUN PHARMACEUTICAL INDUSTRIES LTD.
More recommendations
Chart SUN PHARMACEUTICAL INDUSTRIES LTD.
Duration : Period :
Sun Pharmaceutical Industries Ltd. Technical Analysis Chart | SUNPHARMA | INE044A01036 | MarketScreener
Technical analysis trends SUN PHARMACEUTICAL INDUSTRIES LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 32
Last Close Price 773,95 INR
Average target price 763,75 INR
Spread / Average Target -1,32%
EPS Revisions
Managers and Directors
Dilip Shantilal Shanghvi Managing Director & Executive Director
C. S. Muralidharan Chief Financial Officer
Israel Makov Non-Executive Chairman
Atanu Roy SVP & Chief Information Officer
Ashok I. Bhuta Compliance Officer & Senior GM-Secretarial